Thus, increased levels of endoglin in some cancer cells has been linked to tumor progression, malignant phenotype and metastasis; among others, in breast carcinoma, melanoma, or Ewing sarcoma [38, 66, 95, 96]. Here, ENG is linked to neoplasm.